Cargando…
Immune Modulation in the Treatment of Amyotrophic Lateral Sclerosis: A Review of Clinical Trials
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease characterized by the degeneration of motor neurons. Though many molecular and genetic causes are thought to serve as predisposing or disease propagating factors, the underlying pathogenesis of the disease is not known. Re...
Autores principales: | Khalid, Syed I., Ampie, Leonel, Kelly, Ryan, Ladha, Shafeeq S., Dardis, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5622209/ https://www.ncbi.nlm.nih.gov/pubmed/28993751 http://dx.doi.org/10.3389/fneur.2017.00486 |
Ejemplares similares
-
Longitudinal biomarkers in amyotrophic lateral sclerosis
por: Huang, Fen, et al.
Publicado: (2020) -
Immunotherapeutic Advancements for Glioblastoma
por: Ampie, Leonel, et al.
Publicado: (2015) -
Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities?
por: Webster, Christopher P., et al.
Publicado: (2017) -
Shortcomings in the Current Amyotrophic Lateral Sclerosis Trials and Potential Solutions for Improvement
por: Katyal, Nakul, et al.
Publicado: (2017) -
Motoneuron firing in amyotrophic lateral sclerosis (ALS)
por: de Carvalho, Mamede, et al.
Publicado: (2014)